Allen J P, Litten R Z, Fertig J B, Sillanaukee P
Division of Clinical and Prevention Research, National Institute on Alcohol Abuse and Alcoholism, Willco Building, Suite 505, 6000 Executive Blvd., MSC 7003, Bethesda, MD 20892-7003, USA.
Am J Addict. 2001;10(s1):s24-s28. doi: 10.1080/10550490150504119.
Although the primary use of biochemical markers of heavy drinking is to assist in screening for alcohol problems, laboratory tests may also aid in early identification of relapse. This report reviews research findings on a new marker, carbohydrate deficient transferrin (CDT), in alcoholics receiving treatment or in follow-up. It also offers recommendations on how CDT may be employed by clinicians monitoring drinking status.
尽管大量饮酒生化标志物的主要用途是辅助筛查酒精问题,但实验室检测也有助于早期发现复发情况。本报告回顾了在接受治疗或随访的酗酒者中关于一种新标志物——缺糖转铁蛋白(CDT)的研究结果。它还就临床医生如何利用CDT监测饮酒状况提供了建议。